That may very well be the case but the debt I describe is not a matter of choice. My understanding is 3bn in the short term will need to be paid.I am not suggesting they wont be able to do it, I am just trying to understand it.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%